Schott Pharma jumps after FY results and 2025 outlook
12/12/2024 07:49
** Shares in Schott Pharma 1SXP.DE jump around 6% in early
Frankfurt trade after the German pharmaceutical packaging
company posted higher FY results and gave an upbeat outlook for
2025
** The company posts FY revenue at 957 million euros, up 7%
y/y; EBITDA comes in at 258 million euros vs 239 million
** For 2025, it expects significant revenue growth at
constant currencies in the high single digits and an increase in
EBITDA, with EBITDA margin at the 2024 level
** The stock, which has lost 17.8% YTD, tops Germany's
mid-cap index .MDAXI
(Reporting by Ozan Ergenay)
((ozan.ergenay@thomsonreuters.com))